| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 06/22/2011 | EP2336167A1 MHC molecule constructs and their uses for diagnosis and therapy |
| 06/22/2011 | EP2336144A1 Esterified alpha-galactosylceramide |
| 06/22/2011 | EP2336134A1 Fitness assay and methods for reducing resistance of HIV to therapy |
| 06/22/2011 | EP2336133A1 Purine analogs having HSP90-inhibiting activity |
| 06/22/2011 | EP2336111A1 Heterocyclic inhibitors of p38 |
| 06/22/2011 | EP2335732A2 Multiple-variable dose regimen for treating TNF-alpha-related disorders |
| 06/22/2011 | EP2335731A2 Multiple-variable dose regimen for treating TNF-alpha-related disorders |
| 06/22/2011 | EP2335726A1 Fusion molecules and methods for treatment of immune diseases |
| 06/22/2011 | EP2335720A1 Autologous T-cell vaccines materials and methods |
| 06/22/2011 | EP2335700A1 Hepatitis C virus polymerase inhibitors with a heterobicylic structure |
| 06/22/2011 | EP2335494A1 Method for concentrating lipid |
| 06/22/2011 | EP2334706A1 Identification of a conserved inner core oligosaccharide region of moraxella catarrhalis lipopolysaccharide as a vaccine antigen |
| 06/22/2011 | EP2334309A2 Th1 vaccination priming for active immunotheraphy |
| 06/22/2011 | EP2334301A1 Macrocyclics pyrimidines as aurora kinase inhibitors |
| 06/22/2011 | EP2334296A1 Immunomodulating activities |
| 06/22/2011 | EP2334293A2 Compositions comprising polyhydroxyltate fatty alcohol derivatives and the therapeutic uses |
| 06/22/2011 | EP1836226B1 Antibodies against il-13 receptor alpha 1 and uses thereof |
| 06/22/2011 | EP1827488B1 Composition comprising phosphatidyl serine and an antigen or allergen and the use thereof |
| 06/22/2011 | EP1324771B1 Therapeutic and tolerance inducing antibodies |
| 06/22/2011 | EP1290161B1 METHODS FOR MEDIATING GENE SUPPRESION BY USING FACTORS THAT ENHANCE RNAi |
| 06/22/2011 | EP1204683B1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 06/22/2011 | CN1891714B Ligand for herpes simplex virus entry mediator and methods of use |
| 06/22/2011 | CN1809570B [1,2,4 ]triazolo [1,5-a]pyrimidin-2-ylurea derivative and use thereof |
| 06/22/2011 | CN102105448A Phenoxypyridinylamide derivatives and their use in the treatment of PDE4 mediated disease states |
| 06/22/2011 | CN102105155A Polysaccharides extract from dendrobium for treating allergic diseases |
| 06/22/2011 | CN102102066A Cortex acanthopanacis yellow rice wine and production technology thereof |
| 06/22/2011 | CN102101893A Method for enriching and purifying aloe polysaccharides in aloe |
| 06/22/2011 | CN102101886A Variable-conformation recombinant interferon crystal, and three-dimensional structure and use thereof |
| 06/22/2011 | CN102100903A Capsule preparation of pidotimod sylvite and preparation thereof |
| 06/22/2011 | CN102100899A Preparation technology of new integrative formulation of prepared common monkshood daughter root decoction for regulating middle |
| 06/22/2011 | CN102100898A Preparation technology of new integrative formulation of pinellia decoction for purging stomach fire and production method thereof |
| 06/22/2011 | CN102100895A Technology for preparing novel integrative dosage form of decoction for tonifying middle-Jiao and Qi |
| 06/22/2011 | CN102100889A Preparation technology of new integrative formulation of spleen-returning decoction |
| 06/22/2011 | CN102100888A Preparation technology and production method of new integrative formulation of major green-blue dragon decoction |
| 06/22/2011 | CN102100886A Technology and method for preparing novel combined formulation of relieving-edema decoction |
| 06/22/2011 | CN102100885A Preparation technology and production method of integrated minor bupleurum decoction novel dosage form |
| 06/22/2011 | CN102100875A Process method for microwave assistant supercritical extraction of active ingredients of curcuma |
| 06/22/2011 | CN102100835A Plague-removing and cystoma-treating traditional veterinary medicament and preparation method thereof |
| 06/22/2011 | CN102100815A Preparation technology of new formulation of integrative six gentlemen decoction and production method thereof |
| 06/22/2011 | CN102100805A Composition for relieving physical fatigue and enhancing immunologic function, preparation method thereof and application thereof |
| 06/22/2011 | CN102100792A Preparation technology of new integrative formulation of siwu decoction and production method thereof |
| 06/22/2011 | CN102100784A Animal immunoenhancement taking Echinacea as main component |
| 06/22/2011 | CN102100783A Animal immunity-enhanced oral liquid using echinacea purpurea as main ingredient |
| 06/22/2011 | CN102100782A Granulated immunopotentiator for pig and poultry and preparation method thereof |
| 06/22/2011 | CN102100781A Echinacea chewable tablet for dogs and cats |
| 06/22/2011 | CN102100755A Preparation technology of integrated ephedra, aconite and asarum decoction novel dosage form |
| 06/22/2011 | CN102100730A Traditional Chinese medicine for improving poultry immunity |
| 06/22/2011 | CN102100728A Technology and method for preparing novel combined formulation of jade-screen powder |
| 06/22/2011 | CN102100725A Preparation technology of extracting total alkaloid extraction from Gansu whin |
| 06/22/2011 | CN102100724A Method for processing eucommia ulmoides bark and preparing handicraft by eucommia ulmoides branch and root |
| 06/22/2011 | CN102100718A Process for preparing echinacea purpurea extracts |
| 06/22/2011 | CN102100717A Process for preparing echinacea purpurea extracts |
| 06/22/2011 | CN102100716A Extraction process of effective components of Echinacea |
| 06/22/2011 | CN102100715A Preparation of powder and injection preparations of echinacea purpurea polysaccharides |
| 06/22/2011 | CN102100714A Method for extracting active ingredients of Echinacea through supercritical carbon dioxide |
| 06/22/2011 | CN102100710A Fermentation processing method for ginseng and research and development of related products thereof |
| 06/22/2011 | CN102100699A Composition of coral calcium hydroxide and arginine and application thereof |
| 06/22/2011 | CN102100691A Application of formononetin in preparation of anticomplement medicines |
| 06/22/2011 | CN102100690A Application of flavonoids compounds in preparation of anticomplement medicaments |
| 06/22/2011 | CN102100363A Application of salvianolic acid B in preparation of antifatigue health-care food or antifatigue medicament |
| 06/22/2011 | CN101862418B Rehabilitation capsule of drug-taking patient |
| 06/22/2011 | CN101538293B Method for preparing secoisolariciresinol diglucoside and ferulic acid glucoside or ferulic acid glucoside ethyl ester |
| 06/22/2011 | CN101530548B Composition with multiple health-care functions and preparation method thereof |
| 06/22/2011 | CN101456904B Rhamnose bacterium lacticum Pr2 peptide and coding gene thereof, separation method and application |
| 06/22/2011 | CN101434650B Bursa pentapeptide, deriving peptide thereof and use thereof |
| 06/22/2011 | CN101422427B Magnesium isoglycyrrhizinate cream and preparation method and use thereof |
| 06/22/2011 | CN101416996B Plant desensitizer and preparation method thereof |
| 06/22/2011 | CN101396378B Nano gene peptides products and preparation method and use thereof |
| 06/22/2011 | CN101361918B Traditional Chinese medicine preparation for enhancing immunity and promoting sleep |
| 06/22/2011 | CN101327315B Use of maltose binding protein as immunopotentiator |
| 06/22/2011 | CN101322774B Medicament composition with fatigue-resisting function and preparation method and application thereof |
| 06/22/2011 | CN101264316B Preparation of medicinal protolysate |
| 06/22/2011 | CN101239980B Immunity receptor regulator couplet precursor, couplet and application thereof |
| 06/22/2011 | CN101115742B Heterocycle derivatives as histone deacetylase (hdac) inhibitors |
| 06/22/2011 | CN101031569B Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta |
| 06/22/2011 | CN101002825B Method for preparing Duzhong soft capsule rich in alpha-linolenic acid and effective component of bark of eucommia |
| 06/22/2011 | CN101001857B 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 06/21/2011 | US7964713 Nucleotide sequences which code polypeptide for use in human therapeutics ad diagnostics |
| 06/21/2011 | US7964703 DNAX Cytokine Receptor Subunits (DCRS) 5 cytokine receptors modulators; multiple sclerosis, rheumatoid arthritis, osteoarthritis, inflammatory bowel disease, diabetes, psoriasis, sepsis or in allogeneic transplant; chronic Th1 mediated disease |
| 06/21/2011 | US7964646 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/21/2011 | US7964592 2,4-di (phenylamino) pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 06/21/2011 | US7964397 Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions |
| 06/21/2011 | US7963935 Microprojection array having a beneficial agent containing coating |
| 06/21/2011 | CA2495386C Protein kinase inhibitors and uses thereof |
| 06/21/2011 | CA2486336C Pentafluorosulfanylbenzoylguanidines, process for their preparation, their use as medicament or diagnostic aid, and medicament comprising them |
| 06/21/2011 | CA2474192C Nicotinamide derivates useful as p38 inhibitors |
| 06/21/2011 | CA2473468C Amides of aminoalkyl-substituted azetidines, pyrrolidines, piperidines and azepanes |
| 06/21/2011 | CA2472341C Phosphorus-containing compounds & uses thereof |
| 06/21/2011 | CA2472188C Polymeric gel system for the controlled delivery of codrugs |
| 06/21/2011 | CA2462537C Method for preparing a compound for interaction of active substances with a porous support using supercritical fluid |
| 06/21/2011 | CA2435681C Multivalent meningococcal polysaccharide-protein conjugate vaccine |
| 06/21/2011 | CA2405290C Vaccine against cancerous diseases |
| 06/21/2011 | CA2386019C Methods related to immunostimulatory nucleic acid-induced interferon |
| 06/21/2011 | CA2359115C Acyl derivatives which treat vla-4 related disorders |
| 06/21/2011 | CA2345079C Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 06/21/2011 | CA2199474C Inhibitory or blocking agents of molecular generating and/or inducing functions |
| 06/21/2011 | CA2172392C Methods of inhibiting phagocytosis |
| 06/21/2011 | CA2171336C Recombinant il4 antibodies useful in treatment of il4 mediated disorders |
| 06/16/2011 | WO2011071059A1 T cell activation inhibitor, pharmaceutical composition containing same, and screening method for t cell activation inhibiting substance |
| 06/16/2011 | WO2011071039A1 Identification of hla-dr4 epitope and use for treatment of arthritis |